DOI QR코드

DOI QR Code

Experimental infection of a porcine kidney cell line with hepatitis A virus

  • Dong-Hwi Kim (Department of Infectious Diseases, College of Veterinary Medicine, Konkuk University) ;
  • Da-Yoon Kim (Department of Infectious Diseases, College of Veterinary Medicine, Konkuk University) ;
  • Jae-Hyeong Kim (Department of Infectious Diseases, College of Veterinary Medicine, Konkuk University) ;
  • Kyu-Beom Lim (Department of Infectious Diseases, College of Veterinary Medicine, Konkuk University) ;
  • Joong-Bok Lee (Department of Infectious Diseases, College of Veterinary Medicine, Konkuk University) ;
  • Seung-Yong Park (Department of Infectious Diseases, College of Veterinary Medicine, Konkuk University) ;
  • Chang-Seon Song (Department of Infectious Diseases, College of Veterinary Medicine, Konkuk University) ;
  • Sang-Won Lee (Department of Infectious Diseases, College of Veterinary Medicine, Konkuk University) ;
  • In-Soo Choi (Department of Infectious Diseases, College of Veterinary Medicine, Konkuk University)
  • Received : 2023.05.10
  • Accepted : 2023.06.07
  • Published : 2023.06.30

Abstract

The hepatitis A virus (HAV) induces severe acute liver injury and is adapted to human and monkey cell lines but not other cells. In this study, the HAV was inoculated into porcine kidney (PK-15) cells to determine its infectivity in porcine cells. The growth pattern of the HAV in PK-15 cells was compared with its growth pattern in fetal rhesus kidney (FRhK-4) cells. The growth of HAV was less efficient in PK-15 cells. In conclusion, HAV replication was verified in PK-15 cells for the first time. Further investigations will be needed to identify the HAV-restrictive mechanisms in PK-15 cells.

Keywords

Acknowledgement

This research was supported by the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry (IPET) through Agriculture, Food, and Rural Affairs Convergence Technologies Program for Educating Creative Global Leader Program, funded by Ministry of Agriculture, Food, and Rural Affairs (MAFRA) (grant number: 320005-04-4-SB0a0).

References

  1. Cohen JI, Ticehurst JR, Purcell RH, Buckler-White A, Baroudy BM. Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J Virol 1987;61:50-59. https://doi.org/10.1128/jvi.61.1.50-59.1987
  2. Feng Z, Hensley L, McKnight KL, Hu F, Madden V, Ping L, Jeong SH, Walker C, Lanford RE, Lemon SM. A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature 2013;496:367-371. https://doi.org/10.1038/nature12029
  3. Nainan OV, Xia G, Vaughan G, Margolis HS. Diagnosis of hepatitis a virus infection: a molecular approach. Clin Microbiol Rev 2006;19:63-79. https://doi.org/10.1128/CMR.19.1.63-79.2006
  4. World Health Organization Regional Office for the Eastern Mediterranean (WHO EMRO). Hepatitis [Internet]. WHO EMRO, Cairo [2023 May 10]. Available from: https://www.emro.who.int/health-topics/hepatitis/introduction.html.
  5. Feng Z, Lemon SM. Peek-a-boo: membrane hijacking and the pathogenesis of viral hepatitis. Trends Microbiol 2014;22:59-64. https://doi.org/10.1016/j.tim.2013.10.005
  6. Vaughan G, Goncalves Rossi LM, Forbi JC, de Paula VS, Purdy MA, Xia G, Khudyakov YE. Hepatitis A virus: host interactions, molecular epidemiology and evolution. Infect Genet Evol 2014;21:227-243. https://doi.org/10.1016/j.meegid.2013.10.023
  7. Daniels D, Grytdal S, Wasley A; Centers for Disease Control and Prevention (CDC). Surveillance for acute viral hepatitis: United States, 2007. MMWR Surveill Summ 2009;58:1-27.
  8. Provost PJ, Hilleman MR. Propagation of human hepatitis A virus in cell culture in vitro. Proc Soc Exp Biol Med 1979;160:213-221. https://doi.org/10.3181/00379727-160-40422
  9. Balayan MS. Natural hosts of hepatitis A virus. Vaccine 1992;10 Suppl 1:S27-S31. https://doi.org/10.1016/0264-410X(92)90537-T
  10. Lanford RE, Walker CM, Lemon SM. Nonhuman primate models of hepatitis A Virus and hepatitis E virus infections. Cold Spring Harb Perspect Med 2019;9:a031815.
  11. Kanda T, Sasaki R, Masuzaki R, Matsumoto N, Ogawa M, Moriyama M. Cell culture systems and drug targets for hepatitis A virus infection. Viruses 2020;12:533.
  12. Dotzauer A, Feinstone SM, Kaplan G. Susceptibility of nonprimate cell lines to hepatitis A virus infection. J Virol 1994;68:6064-6068. https://doi.org/10.1128/jvi.68.9.6064-6068.1994
  13. Song YJ, Park WJ, Park BJ, Kwak SW, Kim YH, Lee JB, Park SY, Song CS, Lee SW, Seo KH, Kang YS, Park CK, Song JY, Choi IS. Experimental evidence of hepatitis A virus infection in pigs. J Med Virol 2016;88:631-638. https://doi.org/10.1002/jmv.24386
  14. De Chastonay J, Siegl G. Replicative events in hepatitis A virus-infected MRC-5 cells. Virology 1987;157:268-275. https://doi.org/10.1016/0042-6822(87)90269-8
  15. Schmitz G, Dotzauer A. Proof of hepatitis A virus negative-sense RNA by RNA/DNA-hybrid detection: a method for specific detection of both viral negative- and positive-strand RNA species. Nucleic Acids Res 1998;26:5230-5232. https://doi.org/10.1093/nar/26.22.5230
  16. Frings W, Dotzauer A. Adaptation of primate cell-adapted hepatitis A virus strain HM175 to growth in guinea pig cells is independent of mutations in the 5' nontranslated region. J Gen Virol 2001;82(Pt 3):597-602. https://doi.org/10.1099/0022-1317-82-3-597